This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US
September 23-26, 2024
Hynes Convention CenterBoston, MA

Semsi Ensari
Sr Director, Process Development at Kite Pharma
Advisor

Profile

Semsi Ensari is a Senior Director at Kite Pharma leading Process Technology and Materials Development team which collaborates, develops, and enables the use of innovative and off-the-shelf technologies and materials for the manufacturing of next generation cell therapy products. Previously, Semsi built and led a team of Southern California MSAT leads in support of clinical and commercial manufacturing of cell therapy and viral vector manufacturing operations. Prior joining Kite, Semsi held positions with increasing responsibilities in Research, Process Development and Manufacturing at Schering-Plough, Ambrx, and Genentech. Over the course of 20 years of service, Semsi has a proven track record in successfully developing, implementing and maintaining processes for clinical and commercial production of cell and gene therapies, therapeutic proteins, and antibodies. Semsi holds a Bachelor of Science in Chemical Engineering from Bogazici University in Turkey, Master’s and PhD in Biochemical Engineering from University of California, Irvine.

At this event